Ubs Group Ag Morpho Sys Ag Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$17.36 - $19.34 $20.2 Million - $22.5 Million	-1,164,695 Reduced 99.72%	3,317 $60,000
Q1 2024 May 13, 2024	BUY	$8.6 - $18.18 $10 Million - $21.2 Million	1,167,212 Added 145901.5%	1,168,012 $21.2 Million
Q4 2023 Feb 09, 2024	SELL	$4.55 - $9.9 $468 - $1,019	-103 Reduced 11.41%	800 $7,000
Q3 2023 Nov 09, 2023	SELL	$6.72 - $8.6 $7,284 - $9,322	-1,084 Reduced 54.55%	903 $6,000
Q2 2023 Aug 11, 2023	SELL	$3.95 - $7.74 $1,627 - $3,188	-412 Reduced 17.17%	1,987 $14,000
Q1 2023 May 12, 2023	BUY	$3.56 - $5.22 $5,542 - $8,127	1,557 Added 184.92%	2,399 $9,000
Q4 2022 Feb 08, 2023	SELL	$3.21 - $5.74 $13,799 - $24,676	-4,299 Reduced 83.62%	842 $3,000
Q3 2022 Nov 10, 2022	BUY	$4.14 - $22.13 $11,724 - $62,672	2,832 Added 122.65%	5,141 $26,000
Q2 2022 Aug 10, 2022	BUY	$4.51 - $7.39 $6,616 - $10,841	1,467 Added 174.23%	2,309 $11,000
Q1 2022 May 16, 2022	SELL	$5.87 - $9.73 $23,397 - $38,783	-3,986 Reduced 82.56%	842 $5,000
Q4 2021 Feb 14, 2022	BUY	$9.08 - $12.45 $36,574 - $50,148	4,028 Added 503.5%	4,828 $46,000
Q3 2021 Nov 15, 2021	SELL	$11.76 - $19.51 $235 - $390	-20 Reduced 2.44%	800 $9,000
Q2 2021 Aug 13, 2021	SELL	$18.95 - $23.95 $113 - $143	-6 Reduced 0.73%	820 $15,000
Q1 2021 May 12, 2021	SELL	$21.56 - $30.66 $25,333 - $36,025	-1,175 Reduced 58.72%	826 $18,000
Q4 2020 Feb 11, 2021	BUY	$24.81 - $30.33 $28,779 - $35,182	1,160 Added 137.93%	2,001 $56,000
Q3 2020 Nov 12, 2020	BUY	$30.28 - $35.72 $454 - $535	15 Added 1.82%	841 $26,000
Q2 2020 Jul 31, 2020	BUY	$24.08 - $33.35 $626 - $867	26 Added 3.25%	826 $26,000
Q3 2019 Nov 14, 2019	SELL	$24.18 - $31.58 $17,457 - $22,800	-722 Reduced 47.44%	800 $22,000
Q2 2019 Aug 14, 2019	SELL	$23.24 - $26.76 $2,416 - $2,783	-104 Reduced 6.4%	1,522 $36,000
Q1 2019 May 14, 2019	BUY	$22.55 - $29.84 $36,666 - $48,519	1,626 New	1,626 $37,000
Q3 2018 Nov 14, 2018	SELL	$26.64 - $35.66 $20,299 - $27,172	-762 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$25.15 - $30.6 $19,164 - $23,317	762 New	762 $23,000

Others Institutions Holding MOR

# of Institutions

Shares Held

1.8M

Call Options Held

Put Options Held

14.7K

View Full List

About MorphoSys AG

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

More about MOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account